Voltradol Medicated Plaster

Voltadol (known as Voltarol or Voltarén in other markets) is a leading brand in topical pain relief medication, specifically formulated with Diclofenac sodico. The brand was originally developed by the Swiss pharmaceutical giant Ciba-Geigy, which later merged with Sandoz to form Novartis. In recent years, the consumer healthcare joint venture between GSK and Novartis resulted in the brand moving to Haleon, following a successful demerger in 2022. Manufacturing occurs across several specialist pharmaceutical facilities in Europe and beyond, supporting its global distribution as a trusted over-the-counter remedy for joint and muscle pain.

The medicated plaster format shown in the image is designed for localized treatment of inflammatory pain. As part of Haleon's portfolio, the brand benefits from a dedicated global supply chain focused exclusively on consumer health products. The packaging featuring Italian text indicates distribution specifically tailored for the Italian market through local pharmaceutical networks.